Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts FENC Hot Sheet
Join SI Premium – FREE
Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Accenture downgraded by TD Cowen on AI concerns
- Ennis (EBF) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
